A clinical trial of RV521 in healthy volunteers

Registry ID

EUCTR2017-001282-24

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

ReViral Ltd

Start date

2017-06-21

Completion date

2017-10-31

Last update

2026-08-16

Conditions

• Respiratory Syncytial Virus Infection

Summary

To evaluate the antiviral activity of RV521 compared to placebo in healthy adult subjects inoculated with RSV-A Memphis 37b.

Locations

• , , UK

Related clinical trials

• Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
• A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children
• Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )

View on source registry